Friday, April 28th Poster and Exhibit Viewing Session 15:30-17:30

 

Poster Station 1 

Clinical Science

Poster Start Time Abstract Title Presenter
15 15:35 Monitoring of Adverse Events in Patients Opioid Users of a Unit of Pain Relief and Palliative Care a Referral Hospital Carla Ángel Obregón, Santiago, Chile
16 15:40 Management of Adverse Events and Assessment of Adherence in Naïve and Rotation Potent Opioid Patients of Unit Pain Relief and Palliative Care Prof. Sulamita Miranda Nam, Santiago Chile
11 15:45 Cardiotoxicity Associated with Trastuzumab in Adjuvant Treatment of Early Breast Cancer Ms.Celia Aparicio Rubio, Alzira, Spain
12 15:50 The Cytoprotective Role of Amifostine in the Re-irradiation of Head and Neck Cancer Prof. Jens Buentzel, Nordhausen, Germany
17 15:55 Drug Safety Profile Tyrosine Kinase Inhibitors Epidermal Factor Receptor (EGFR) and Anaplastic Lymphoma Kinase (ALK) Used in Patients with Advanced Lung Cancer Prof. Sulamita Miranda Nam, Santiago, Chile
13 16:00 A Case of Nivolumab-induced Liver Toxicity in Metastatic Lung Cancer Ms. Wei Liu, Fitzroy, Australia
14 16:05 Cold Agglutinin Disease: A Rare Case Managed with Rituximab Ms. Wei Liu, Fitzroy, Australia
18 16:10 Enzalutamide in Metastatic Castration-Resistant Prostate Cancer Before Chemotherapy Mrs. Cristina Mondelo Garcia, A Coruña, Spain
19 16:15 Pembrolizumab Induced Auto-immune Diabetes and Hepatitis Ms. Debra Paull, St Leonards, Australia
21 16:20 Physicochemical Stability of Oxaliplatin Beta Infusion Concentrate and Infusion Solutions in Polyolefin Bags Prefilled with 5% Glucose Vehicle Solution Over a 28 Day Period Dr. Iman Sarakbi, Mainz, Germany
22 16:25 Cost Avoidance, Safety, and Adherence Through Two Week Oral Chemotherapy Clinic Follow-Up Dr. Sachin Shah, DALLAS, USA
23 16:30 Clinical Pharmacy Service in Children Cancer Centre and Bone Marrow Transplant Unit at a local hospital in Hong Kong Mr. Kai Him So, Hong Kong, Hong Kong
24 16:35 The Characteristics of Prescription-Related Medication Errors and the Effect of Implementing Chemotherapy Regimen Protocols in Proton and Heavy Ion Radiation Oncology Settings in China Dr. Bo Yu, Shanghai, China

Poster Station 2

Process Improvement/ Pharmacoeconomics

Poster Start Time Abstract Title Presenter
28 15:35 Diffusion of Innovation in Ambulatory Chemotherapy: Case Study in Lebanon Miss Racha Sabbagh Dit Hawasli, Surrey, United Kingdom
25 15:40 Developing an Oral Anticancer Drug Disposal Program Dr. Lisa Holle, Storrs, USA
26 15:45 Standardizing Intrathecal Chemotherapy Preparation & Delivery Dr. Lisa Holle, Storrs, USA
27 15:50 Assessing the Impact of a National Policy on the Safe Handling of Antineoplastics in Ghana Miss Asomaniwaa Owusu-Ansah, Accra, Ghana
29 15:55 Prevalence of Poly-pharmacy in the Prostate Cancer Clinic and Patient Interest in a Medicine Review Service Mr. Joseph Williams, London, United Kingdom
30 16:00 Survey of Chemotherapy Regimen Checks for Oral Anticancer Agents by Pharmacist in the Cancer Designated Hospitals of the NHO/NCC in Japan Mr. Takahiro Ohta, Kashiwa, Japan

Poster Station 2

Translational / Basic Science

Poster Start Time Abstract Title Presenter
32 16:10 Development of an Algorithm for Risk Assessment and Allocation of Preparation of Monoclonal Antibodies Dr. Tiene Bauters, Ghent, Belgium

Poster Station 2

Encore Presentation

Poster Start Time Abstract Title Presenter
35 16:15 Electronic Simulation for Chemotherapy Checking Training Ms. Carole Chambers, Calgary, Canada
36 16:20 Investigation in Reduction of Occupational Exposures from Anti-cancer Agents Using the Infusion Set Which Incorporated BD Phaseal™ System Mr. Toshio Kurihara, Tanabe city Wakayama prefecture, Japan
37 16:25 The Multidisciplinary Approach to Enhance Efficiency in Chemotherapy Day Centre by using Six Sigma Methodology Mr. Kam Lam, Hong Kong, Hong Kong
38 16:30 Educational Impact and Registrant Perspectives for an Online Fundamental Oncology Pharmacy Conference in Canada Prof. Tara Leslie, Edmonton, Canada & Dr. John Wiernikowski, Hamilton, Canada
39 16:35 Assessment of a New Closed System Drug-Transfer Device (CSTD) at 13 U.S. Cancer Centers Dr. Timothy Tyler, Palm Springs, USA

Poster Station 2

Trainee

Poster Start Time Abstract Title Presenter
33 16:40 Assessment of Adherence in Patient’s Opioid Users in the Palliative Care Unit Rodrigo Vega Lepe, Santiago, Chile
34 16:45 Empirical Treatment of Progressive Multifocal Leucoencephalopathy with Mefloquine and Mirtazapine in an Immunocompetent Patient with Multiple Myeloma Mrs. Josune García de Andoín, San Sebastian, Spain